Delta, Kelowna, BC – February 24, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site,
www.potcasts.ca
release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts #535, Cannabis News and Stocks on the Move; (NEO: MGW) (OTCQB: MGWFF) (TSX: APHA) (NASDAQ: APHA) (NASDAQ: TLRY) (CSE: AUSA)
SHARE PODCAST:
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com “Potcast” featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few public and private company announcements.
Everest BioPharma International Inc.
announced
that it has received, in February 2021, its notification of Eligible Business corporation (“EBC”) under the BC Venture Capital Act allowing BC investors a 30% Tax Credit. The Company is presently completing the internal build-out of its state-of-the art cannabis extraction systems in Kelowna, BC. The first sales of live rosen and its derivatives are expected in May, 2021.
Everest is installing large capacity ice water bubble hash solventless processing equipment with ancillary rosen presses, which also allows the ability for “organic” registration, adding further value to its products.
Nigel Boast, President and CEO of Everest BioPharma stated; “Our registration as an eligible business corporation “EBC” in BC (attracting a 30% tax credit) will facilitate funding required for us to fully implement our business plan which firstly focuses on tolling service fees and then the sale of our proprietary medical CBD products. Two recent standard processing license sales: Premium 5 with a similar business model ($40M), and LYF Food ($43M) indicate a high valuation for Everest.
Rob Hatch, COO of Everest BioPharma stated; “By processing from frozen, we save our tolling customers time and money because there is no requirement to trim and dry the product. There are approximately 147 standard cultivation licenses in Canada without extraction licenses.”
Aphria Inc. (
TSX: APHA
) (
NASDAQ: APHA
), a leading global cannabis-lifestyle consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, and Tilray, Inc. (
NASDAQ: TLRY
), a global pioneer in cannabis research, cultivation, production and distribution,
announced
the launch of the website:
www.aphriatilraytogether.com
. This new, dedicated resource seeks to provide shareholders of both companies with pertinent information, news and updates leading up to the special meetings of shareholders at which Aphria’s and Tilray’s respective shareholders will vote on the resolutions necessary to implement the proposed business combination of the two companies. The website will also allow shareholders and other interested parties to register for Transaction updates that are made publicly available, so they receive information directly to their e-mail addresses.
As disclosed in the preliminary joint proxy statement and management information circular filed with regulators on February 19, 2021, both companies are pleased that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, has expired in relation to the Transaction. In addition, the companies have received a no-action letter from the Competition Bureau of Canada in respect of the Transaction, which confirms that the Competition Bureau does not intend to challenge the Transaction under the Competition Act (Canada). The receipt of the HSR Clearance and the Competition Act Approval are two of the required regulatory clearances that need to be obtained to satisfy the conditions to closing of the Transaction. The closing of the Transaction is currently expected to occur in the second quarter of calendar year 2021.
Irwin D. Simon, Aphria’s Chairman and Chief Executive Officer commented, “The receipt of HSR Clearance and Competition Act Approval represent a significant step forward in bringing together these two companies, and we are incredibly pleased that we remain on track to complete our business combination in the second quarter of calendar year 2021. Together, Aphria and Tilray expect to have a robust strategic footprint in Canada and internationally with the operational scale necessary to compete more effectively in today’s consolidating cannabis market. We believe our strong, flexible balance sheet, cash position and access to capital will provide us with the ability to accelerate long-term sustainable growth and deliver attractive returns for shareholders.”
Australis Capital Inc. (
CSE: AUSA
) (
OTC: AUSAF
)
announced today
that, further to its press release dated January 5, 2021, the Company has entered into a definitive agreement with the principals of ALPS for the acquisition of 51% of the issued and outstanding shares in ALPS. The Definitive Agreement has an option permitting the Company to acquire the remaining 49%. Furthermore, the ALPS Transaction also includes the appointment of Terry Booth as AUSA’s CEO upon completion.
Since its management buyout from Aurora Cannabis in May 2020, ALPS has rapidly built a blue-chip roster of global customers and a growing pipeline of potential new deals. ALPS currently is executing on a number of contracts, including four that were signed and announced in the past month:
- Aurora Cannabis – Annual ongoing services contract, multiple locations globally
- Cann Group – Cannabis facility contract + APIS extended services contract in Australia
- Multiple undisclosed cannabis related contracts in the U.S.
- Bluehouse Greenhouse – 62 acre vegetable facility contract in California, U.S.
- Vertical Harvest – 200,000 sqft multi-level urban facility contract in Wyoming, U.S.
- Aldershot Greenhouses – 200,000 sqft facility expansion contract in Ontario, Canada
- 200,000 sqft small plant production facility in Finland
- 20,000 sqft crop research facility in northern U.S.
- Tropica – facility for the cultivation of aquarium plants in Germany
- McMaster University, life Science Centre, Ontario, Canada
- Queen, Denmark – ornamental plants
- Middle East – large fruit & vegetable facility
The ALPS Transaction, upon closing, will be immediately accretive to AUSA results, with further material growth anticipated in the coming months.
Maple Leaf Green World Inc. (
NEO: MGW
) (
OTCQB: MGWFF
)
announced
that it has signed an agreement with Hempacco Co. Inc., a vertically integrated California-based Hemp CBD, CBG R&D, marketing, and manufacturing company, to develop, manufacture and market its new brand of CBG Hemp cigarettes.
The Agreement aims to develop a new CBG hemp cigarette brand for Maple Leaf using their California-grown hemp. Hempacco will handle all of the research, development, and manufacturing of a retail-ready 20-pack CBG-rich hemp cigarette brand.
“I’m excited to work with Hempacco to develop our brand of CBG hemp cigarettes; this is a pivot for our company after identifying the growing hemp cigarette space and the market opportunity not only in the USA, but also in Canada and internationally”, said Raymond Lai, CEO of Maple Leaf, “Our CBG farm is minutes away from Hempacco’s manufacturing location, which makes it an amazing opportunity to have our own seed to shelve product and deliver an incredible hemp smokable quality experience to the consumer,” Raymond concluded.
“It’s been a pleasure working with Raymond and his team to launch Maple Leaf’s new CBG brand in our quest to disrupt Tobacco,” said Sandro Piancone, CEO of Hempacco. “We’re committed to a fast launch of the CBG hemp cigarette brand and following it up with an eCommerce portal that integrates picking, packing, and shipping all from one location close to the Maple Leaf’s farm,” Sandro concluded.
The hemp cigarette private label manufacturing agreement is for five (5) years consists of two (2) phases. The first phase is hemp cigarette product development, including Research & Development, Business Modelling, and hemp cigarette white label Manufacturing sub-phases. Hempacco will undertake all the necessary work for the three (3) sub-phases, including packaging and shipping, where Maple Leaf supplies raw hemp material. Maple Leaf and Hempacco will jointly develop branding and packaging artwork that Hempacco will manufacture. The second phase is to establish an e-commerce Strategy, which will expand Maple Leaf’s online and social media presence by developing a full e-commerce platform. Through the Company’s new hemp cigarette online store, CBG hemp cigarettes, packaged flower jars, and subsequent product developments will be available for purchase and shipped across the United States and Overseas. Both phases will commence immediately.
Hempacco will invest in the brand by paying for all the initial start-up costs associated with both phases. Maple Leaf will contribute to the manufacturing and order processing cost when sales are made. As compensation for Hempacco’s services, Maple Leaf will pay Hempacco two (2) million common shares at $0.075 per share for phase 1 and one (1) million common shares at $0.075 per share for phase 2 provided that both phases are completed within 45 days after the agreement date and accepted by Maple Leaf. The issuance of three (3) million common shares is subject to Maple Leaf’s Broad of Directors and Neo Stock Exchange’s approval.
The Agreement will leverage Hempacco’s fully integrated supply chain to manufacture, package, market, and distribute Maple Leaf’s CBG Hemp Cigarettes as well as leveraging Maple Leaf’s digital branding artwork, expertise in cultivating high quality, organic CBG Hemp, and its role as a gateway for penetrating international markets. By utilizing the resources from both Maple Leaf and Hempacco, the Agreement will disrupt the cigarette industry by providing a naturally great-tasting alternative to traditional tobacco and nicotine cigarettes. Hemp cigarettes are also a great alternative to marijuana by offering the non-psychoactive effects caused by THC with the added benefits of CBG.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at
https://www.investorideas.com/Audio/Potcasts.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
To hear more Investorideas.com podcasts visit:
https://www.investorideas.com/Audio/
.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Investors can trade these stocks and other ideas on our site using our
list of top stock trading apps
including Robinhood, Acorn, Stash and others.
About Investorideas.com – News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles,
podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns:
Crypto Corner
,
Play by Play
sports and stock news column,
Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast and column,
Cleantech and Climate Change
,
Exploring Mining
the
AI Eye
.
Disclaimer/Disclosure:
Investorideas.com
is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp
Learn more about publishing your news release and our other news services on the Investorideas.com newswire
https://www.investorideas.com/News-Upload/
and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
https://www.facebook.com/Investorideaspotcasts/
https://www.instagram.com/investorideas_potcast/
Download our
Mobile App
for iPhone and Android
Contact Investorideas.com
800-665-0411
